GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Akums Drugs and Pharmaceuticals Ltd
Akums Drugs recommends Final cum Special Dividend
DIVIDEND ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 14 May 2026, 01:45 PM IST  ·  BSE ID: b85fb140-f3f1-4ecf-81d6-43e017175d3b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has proposed giving shareholders a Final cum Special Dividend.
🤖 AI Summary
  • Akums Drugs and Pharmaceuticals Ltd Board recommended a Final cum Special Dividend.
  • The specific dividend amount per share remains to be announced in a subsequent filing.
  • Recommendation is subject to approval by shareholders at the next Annual General Meeting.
  • Approved dividend, if any, will be disbursed within 30 days of the Annual General Meeting.
🏢 How This Affects the Company
💰
Financial Impact
A declared dividend will result in a cash outflow from the company's reserves, impacting its overall cash position.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action following this recommendation.
👤
Who Is Affected
All shareholders on the record date, once announced, will be eligible to receive the dividend if approved at the Annual General Meeting.
🔍
Management Signal
The dividend recommendation indicates management's intent to distribute a portion of profits to shareholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome — wait for dividend per share announcement
Annual General Meeting date — note for shareholder approval
Dividend record date — confirm eligibility for payment
LOW RISK This filing is a routine dividend recommendation, posing no immediate financial or operational risk.
💡 Investor Takeaway
Akums Drugs and Pharmaceuticals Ltd Board has recommended a Final cum Special Dividend. The exact dividend amount per share is pending announcement. Shareholder approval at the Annual General Meeting is required for dividend payment, which will occur within 30 days post-AGM.
⚖️ Strengths & Concerns

✅ Positives

  • The recommendation for a dividend indicates a level of financial stability and available distributable profits.
  • A special dividend component suggests the company may have recognized an exceptional profit or strong financial performance.
📅 Company Track Record
No previous filings found for Akums Drugs and Pharmaceuticals Ltd (BSE: 544222) to provide historical context regarding dividend declarations or financial performance trends.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.